What Do Current Information and Evidence Suggest to Us for Oxytocin Use During Caesarean Section?


Creative Commons License

Gunaydin B., TAŞ TUNA A.

TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, vol.43, no.2, pp.113-115, 2015 (ESCI) identifier identifier identifier

Abstract

Oxytocin is the first-line agent in the prevention and treatment of uterine atony and maintenance of uterine tone. Since there are several different practices related to the use of oxytocin during caesarean sections, we would like to address the latest information and evidence for rational oxytocin use.